We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
(+13%)
Cap. Flow
+$225M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$154M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$89.6M |
| 3 |
Lockheed Martin
LMT
|
+$86.9M |
| 4 |
BCM
iPath Pure Beta Broad Commodity ETN
BCM
|
+$76.4M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$98.9M |
| 2 |
GE Aerospace
GE
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$67.4M |
| 5 |
Tapestry
TPR
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.01% |
| 2 | Technology | 14.16% |
| 3 | Financials | 12.66% |
| 4 | Industrials | 9.8% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
EOG Resources
EOG
$74.7B
| $100K | ﹤0.01% |
1,182
-5,834
| -83% | -$500K |
|
|
WGL
702
DELISTED
Wgl Holdings
WGL
| $100K | ﹤0.01% |
+2,500
| New | +$104K |
|
703
Invesco
IVZ
$13.3B
| $99K | ﹤0.01% |
2,740
-90
| -3% | -$3.05K |
|
704
PBF Energy
PBF
$7.43B
| $99K | ﹤0.01% |
3,173
+173
| +6% | +$4.72K |
|
|
XEC
705
DELISTED
CIMAREX ENERGY CO
XEC
| $99K | ﹤0.01% |
943
+512
| +119% | +$51.9K |
|
706
American Tower
AMT
$77.7B
| $97K | ﹤0.01% |
1,201
-1,848
| -61% | -$143K |
|
707
Trane Technologies
TT
$107B
| $97K | ﹤0.01% |
1,577
+112
| +8% | +$6.17K |
|
708
iShares Core US Aggregate Bond ETF
AGG
$138B
| $96K | ﹤0.01% |
901
-3,402
| -79% | -$364K |
|
709
Loews
L
$24.4B
| $96K | ﹤0.01% |
1,986
| – | – |
|
710
State Street
STT
$50.7B
| $96K | ﹤0.01% |
1,295
-136
| -10% | -$9.53K |
|
|
TWTR
711
DELISTED
Twitter, Inc.
TWTR
| $96K | ﹤0.01% |
+1,500
| New | +$74.5K |
|
712
Intercontinental Exchange
ICE
$84.1B
| $95K | ﹤0.01% |
2,100
+1,750
| +500% | +$72.1K |
|
713
Prologis
PLD
$137B
| $95K | ﹤0.01% |
2,565
+2,100
| +452% | +$80.8K |
|
714
Cenovus Energy
CVE
$52.3B
| $93K | ﹤0.01% |
3,218
+375
| +13% | +$10.9K |
|
715
Opko Health
OPK
$936M
| $93K | ﹤0.01% |
11,000
| – | – |
|
716
State Street SPDR Dow Jones International Real Estate ETF
RWX
$265M
| $90K | ﹤0.01% |
2,208
| – | – |
|
|
THS
717
DELISTED
Treehouse Foods
THS
| $90K | ﹤0.01% |
+1,301
| New | +$91.5K |
|
|
VMW
718
DELISTED
VMware, Inc
VMW
| $90K | ﹤0.01% |
1,000
| – | – |
|
|
STJ
719
DELISTED
St Jude Medical
STJ
| $90K | ﹤0.01% |
1,449
+124
| +9% | +$7.18K |
|
720
VanEck Brazil Small-Cap ETF
BRF
$21.8M
| $89K | ﹤0.01% |
+3,000
| New | +$95K |
|
721
iShares MSCI Poland ETF
EPOL
$671M
| $89K | ﹤0.01% |
+3,000
| New | +$91.5K |
|
722
Snap-on
SNA
$21.1B
| $89K | ﹤0.01% |
814
+69
| +9% | +$7.16K |
|
|
HSH
723
DELISTED
HILLSHIRE BRANDS CO
HSH
| $89K | ﹤0.01% |
2,660
| – | – |
|
|
VNR
724
DELISTED
Vanguard Natural Resources, LLC
VNR
| $89K | ﹤0.01% |
+3,000
| New | +$84.9K |
|
|
CBNK
725
DELISTED
CHICOPEE BANCORP INC COM STK
CBNK
| $88K | ﹤0.01% |
+5,000
| New | +$88.4K |
|
Similar funds
Bessemer Group's Q4 2013 Portfolio in Review
As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
- Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
- Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
- Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
- Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
- Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
- Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.
Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.